PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status Ben Fulton, Susan C. Short, Allan James, Stefan Nowicki, Catherine McBain, Sarah Jefferies, Caroline Kelly, Jon Stobo, Anna Morris, Aoife Williamson, Anthony J. Chalmers Clinical and Translational Radiation Oncology Volume 8, Pages 12-16 (January 2018) DOI: 10.1016/j.ctro.2017.11.003 Copyright © 2017 The Authors Terms and Conditions
Fig. 1 Study design for PARADIGM-2. Clinical and Translational Radiation Oncology 2018 8, 12-16DOI: (10.1016/j.ctro.2017.11.003) Copyright © 2017 The Authors Terms and Conditions